Form 4: Progyny COO Sells Shares Under 10b5-1 Plan

Progyny's Chief Operating Officer, Melissa B. Cummings, sold 9,578 shares of common stock for $25 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Melissa B. Cummings, Chief Operating Officer of Progyny, Inc., reported a transaction on May 19, 2026.
• She sold 9,578 shares of common stock.
• The sale was executed at a price of $25 per share.
• This transaction was made pursuant to a Rule 10b5-1 trading plan established on December 19, 2025.
• Following this sale, Ms. Cummings beneficially owns 73,371 shares of common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the sale of a notable number of shares by a key executive, despite the transaction being part of a pre-arranged 10b5-1 plan.

Negatives

• A significant number of shares were sold by a key executive.

Risks

• The sale of shares by a Chief Operating Officer could be interpreted by the market as a lack of confidence in the company's future performance, although it was conducted under a pre-established 10b5-1 plan.

Future Outlook

The filing itself does not contain forward-looking statements or guidance regarding the company's future performance. The only forward-looking aspect is the execution of a pre-planned trading strategy.

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, can sometimes create short-term market sentiment shifts. However, the existence of a 10b5-1 plan is designed to mitigate concerns about opportunistic trading based on non-public information, suggesting a structured approach to personal financial management by the executive.

Stakeholder Impact

• Shareholders: May view the sale with caution, although the 10b5-1 plan mitigates concerns about insider trading. The sale reduces the COO's direct stake in the company.
• Employees: May interpret the sale as a signal from management, potentially impacting morale if viewed negatively.
• Creditors/Suppliers: Unlikely to be directly impacted by this specific transaction.

Next Steps

• Monitor future Form 4 filings for any additional insider transactions.
• Observe market reaction to this sale, if any.

Key Dates

Keywords

Progyny, PGNY, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Melissa B. Cummings, Chief Operating Officer, Securities Exchange Act